Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mother's scent may calm preterm infants' breathing

NCT ID NCT07689669

Disease control Sponsor: Ankara Yildirim Beyazıt University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This trial investigates whether exposing preterm infants to their mother's natural body odor can reduce apnea episodes (pauses in breathing) and improve heart rate, oxygen levels, and weight gain. Sixty preterm babies in the NICU are randomly assigned to either receive a cloth carrying their mother's scent for five days or standard care. The study aims to find a simple, non-drug way to support these fragile newborns.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
maternal body odor (via cotton cloth)
What this could lead to
If effective, this simple, low-cost intervention could help stabilize breathing and growth in preterm infants without medication.
What could go wrong
This is a small, early-stage study. The effect may be modest or not reproducible in larger, more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Nov 2022

Finished

Jun 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 28 days

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Preterm infants born between 26 and 37 weeks of gestation * Birth weight between 1000 and 2500 g * Hospitalized in the neonatal intensive care unit for at least 5 days * Receiving oral or enteral feeding * Written informed consent obtained from parent(s) or legal guardian(s) Exclusion Criteria: * Endotracheal intubation, mechanical ventilation, or nasal continuous positive airway pressure * Receiving oxygen therapy * Congenital heart disease * Suspected or confirmed sepsis * Intracranial hemorrhage * Receiving analgesic, sedative, or muscle relaxant therapy * Previous surgical procedure * Development of a medical condition requiring withdrawal from the study or hospitalization for less than 5 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Apnea of prematurity are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Apnea apnea of prematurity Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Apnea of prematurity Prematurity

Contacts and locations

Locations

  • Selcuk University Faculty of Medicine Hospital

    Konya, 06370, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.